The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

Concerns over US economic growth have taken center stage despite a solid corporate earnings season from S&P 500 companies.

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

With semaglutide patents set to expire in 2026, Indian pharma giants are ramping up peptide production and device tie-ups to ...

VHT is attractively valued at 16x forward earnings, but sector momentum is weak and technicals remain bearish. Read why VHT ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Novo Nordisk has reported another significant criticality: the presence of unauthorized versions of its drugs on the US ...